These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 22651800

  • 1. New 5-(nitroheteroaryl)-1,3,4-thiadiazols containing acyclic amines at C-2: synthesis and SAR study for their antileishmanial activity.
    Tahghighi A, Emami S, Razmi S, Rezazade Marznaki F, Kabudanian Ardestani S, Dastmalchi S, Kobarfard F, Shafiee A, Foroumadi A.
    J Enzyme Inhib Med Chem; 2013 Aug; 28(4):843-52. PubMed ID: 22651800
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and in vitro anti-leishmanial activity of 1-[5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-yl]- and 1-[5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl]-4-aroylpiperazines.
    Behrouzi-Fardmoghadam M, Poorrajab F, Ardestani SK, Emami S, Shafiee A, Foroumadi A.
    Bioorg Med Chem; 2008 Apr 15; 16(8):4509-15. PubMed ID: 18321711
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and in vitro leishmanicidal activity of 2-(1-methyl-5-nitro-1H-imidazol-2-yl)-5-substituted-1,3,4-thiadiazole derivatives.
    Foroumadi A, Emami S, Pournourmohammadi S, Kharazmi A, Shafiee A.
    Eur J Med Chem; 2005 Dec 15; 40(12):1346-50. PubMed ID: 16095763
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and anti-leishmanial activity of 5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-amines containing N-[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl] moieties.
    Tahghighi A, Razmi S, Mahdavi M, Foroumadi P, Ardestani SK, Emami S, Kobarfard F, Dastmalchi S, Shafiee A, Foroumadi A.
    Eur J Med Chem; 2012 Apr 15; 50():124-8. PubMed ID: 22336386
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and antileishmanial activity of novel 5-(5-nitrofuran-2-y1)-1,3,4-thiadiazoles with piperazinyl-linked benzamidine substituents.
    Tahghighi A, Marznaki FR, Kobarfard F, Dastmalchi S, Mojarrad JS, Razmi S, Ardestani SK, Emami S, Shafiee A, Foroumadi A.
    Eur J Med Chem; 2011 Jun 15; 46(6):2602-8. PubMed ID: 21501907
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and antileishmanial activity of 5-(5-nitroaryl)-2-substituted-thio-1,3,4-thiadiazoles.
    Alipour E, Emami S, Yahya-Meymandi A, Nakhjiri M, Johari F, Ardestani SK, Poorrajab F, Hosseini M, Shafiee A, Foroumadi A.
    J Enzyme Inhib Med Chem; 2011 Feb 15; 26(1):123-8. PubMed ID: 20578974
    [Abstract] [Full Text] [Related]

  • 7. 2-(Bipiperidin-1-yl)-5-(nitroaryl)-1,3,4-thiadiazoles: Synthesis, evaluation of in vitro leishmanicidal activity, and mechanism of action.
    Mojallal-Tabatabaei Z, Foroumadi P, Toolabi M, Goli F, Moghimi S, Kaboudanian-Ardestani S, Foroumadi A.
    Bioorg Med Chem; 2019 Aug 15; 27(16):3682-3691. PubMed ID: 31300318
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and in vitro leishmanicidal activity of 2-(5-nitro-2-furyl) and 2-(5-nitro-2-thienyl)-5-substituted-1,3,4-thiadiazoles.
    Foroumadi A, Pournourmohammadi S, Soltani F, Asgharian-Rezaee M, Dabiri S, Kharazmi A, Shafiee A.
    Bioorg Med Chem Lett; 2005 Apr 15; 15(8):1983-5. PubMed ID: 15808452
    [Abstract] [Full Text] [Related]

  • 9. Selective leishmanicidal effect of 1,3,4-thiadiazole derivatives and possible mechanism of action against Leishmania species.
    Poorrajab F, Ardestani SK, Foroumadi A, Emami S, Kariminia A, Behrouzi-Fardmoghadam M, Shafiee A.
    Exp Parasitol; 2009 Apr 15; 121(4):323-30. PubMed ID: 19124020
    [Abstract] [Full Text] [Related]

  • 10. Synthesis, antileishmanial activity and cytotoxicity of 2,3-diaryl- and 2,3,8-trisubstituted imidazo[1,2-a]pyrazines.
    Marchand P, Bazin MA, Pagniez F, Rivière G, Bodero L, Marhadour S, Nourrisson MR, Picot C, Ruchaud S, Bach S, Baratte B, Sauvain M, Pareja DC, Vaisberg AJ, Le Pape P.
    Eur J Med Chem; 2015 Oct 20; 103():381-95. PubMed ID: 26383125
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and biological evaluation of 2,3-diarylimidazo[1,2-a]pyridines as antileishmanial agents.
    Marhadour S, Marchand P, Pagniez F, Bazin MA, Picot C, Lozach O, Ruchaud S, Antoine M, Meijer L, Rachidi N, Le Pape P.
    Eur J Med Chem; 2012 Dec 20; 58():543-56. PubMed ID: 23164660
    [Abstract] [Full Text] [Related]

  • 12. Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines.
    Khan I, Zaib S, Ibrar A, Rama NH, Simpson J, Iqbal J.
    Eur J Med Chem; 2014 May 06; 78():167-77. PubMed ID: 24681981
    [Abstract] [Full Text] [Related]

  • 13. Nitroimidazolyl-1,3,4-thiadiazole-based anti-leishmanial agents: synthesis and in vitro biological evaluation.
    Poorrajab F, Ardestani SK, Emami S, Behrouzi-Fardmoghadam M, Shafiee A, Foroumadi A.
    Eur J Med Chem; 2009 Apr 06; 44(4):1758-62. PubMed ID: 18485538
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and Comparison of In Vitro Leishmanicidal Activity of 5-(Nitroheteroaryl)-1,3,4-Thiadiazols Containing Cyclic Amine of Piperidin-4-ol at C-2 with Acyclic Amine Analogues against Iranian Strain of Leishmania major (MRHO/IR/75/ER).
    Tahghighi A, Foroumadi A, Kabudanian-Ardestani S, Mahdian SMA.
    J Arthropod Borne Dis; 2017 Mar 06; 11(1):95-104. PubMed ID: 29026856
    [Abstract] [Full Text] [Related]

  • 15. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
    Sharma R, Pandey AK, Shivahare R, Srivastava K, Gupta S, Chauhan PM.
    Bioorg Med Chem Lett; 2014 Jan 01; 24(1):298-301. PubMed ID: 24314395
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis, antileishmanial, and antifungal biological evaluation of novel 3,5-disubstituted isoxazole compounds based on 5-nitrofuran scaffolds.
    Trefzger OS, Barbosa NV, Scapolatempo RL, das Neves AR, Ortale MLFS, Carvalho DB, Honorato AM, Fragoso MR, Shuiguemoto CYK, Perdomo RT, Matos MFC, Chang MR, Arruda CCP, Baroni ACM.
    Arch Pharm (Weinheim); 2020 Feb 01; 353(2):e1900241. PubMed ID: 31840866
    [Abstract] [Full Text] [Related]

  • 17. Novel antileishmanial chalconoids: synthesis and biological activity of 1- or 3-(6-chloro-2H-chromen-3-yl)propen-1-ones.
    Nazarian Z, Emami S, Heydari S, Ardestani SK, Nakhjiri M, Poorrajab F, Shafiee A, Foroumadi A.
    Eur J Med Chem; 2010 Apr 01; 45(4):1424-9. PubMed ID: 20074836
    [Abstract] [Full Text] [Related]

  • 18. Synthesis of N-(1-methyl-1H-indol-3-yl)methyleneamines and 3,3-diaryl-4-(1-methyl-1H-indol-3-yl)azetidin-2-ones as potential antileishmanial agents.
    Singh GS, Al-Kahraman YM, Mpadi D, Yasinzai M.
    Bioorg Med Chem Lett; 2012 Sep 01; 22(17):5704-6. PubMed ID: 22832310
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and antileishmanial activity of novel pyridinium-hydrazone derivatives.
    Alptuzun V, Cakiroglu G, Limoncu ME, Erac B, Hosgor-Limoncu M, Erciyas E.
    J Enzyme Inhib Med Chem; 2013 Oct 01; 28(5):960-7. PubMed ID: 22803671
    [Abstract] [Full Text] [Related]

  • 20. Dihydropyrido[2,3-d]pyrimidines as a new class of antileishmanial agents.
    Agarwal A, Ramesh, Ashutosh, Goyal N, Chauhan PM, Gupta S.
    Bioorg Med Chem; 2005 Dec 15; 13(24):6678-84. PubMed ID: 16126395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.